Dublin, June 23, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Ventricular Assistance Devices Global Market - Forecast to 2023" report to their offering. The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023 Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR). This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment. Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 3.3.1.1 Increase Incidence of Heart Failure 3.3.1.2 Shortage of Heart Donors 3.3.1.3 Technological Advancements in Vad 3.3.1.4 Rising Geriatric Population 3.3.1.5 Vast Pipeline Products 3.3.1.6 Expansion of Lvad Centers in Emerging Countries 3.3.1.7 New Product Launches 3.3.1.8 Increase in Funding for Lvad Research 3.3.2 Restraints and Threats 3.3.2.1 Adverse Events and Complication With the Implantations of Vad 3.3.2.2 Cost of the Devices 3.3.2.3 Stringent Regulatory Guidelines 3.3.2.4 Lack of Skilled and Trained Professionals 3.3.2.5 Availability of Alternative Products 3.3.2.6 Reimbursement Issues in Emerging Countries 3.4 Regulatory Affairs 3.5 Reimbursement Scenario 3.7 Patent Trends 3.8 Technological Advancements 4 Ventricular Assist Devices Global Market, by Product 4.1 Introduction 4.2 Left Ventricular Assist Devices (Lvad) 4.3 Right Ventricular Assist Devices (Rvad) 4.4 Bi-Ventricular Assist Devices (Bivad) 5 Ventricular Assist Devices Global Market, by Implant Type 5.1 Introduction 5.2 Extracorporeal Vad 5.3 Intracorporeal Vad 5.4 Percutaneous Vad 6 Ventricular Assist Devices Global Market, by Pump Type 6.1 Introduction 6.2 Pulsatile Flow Pump 6.3 Continuous Flow Pump 6.3.1 Centrifugal Flow Pump 6.3.2 Axial Flow Pump 7 Ventricular Assist Devices Global Market, by Patient Type 7.1 Introduction 7.2 Pediatric Vad 7.3 Adult Vad 8 Ventricular Assist Devices Global Market, by Application 8.1 Introduction 8.2 Bridge to Transplant (Btt) 8.3 Bridge to Destination Therapy (Btd) 8.4 Bridge to Recovery (Btr) 9 Regional Analysis 10 Company Developments 11 Major Companies
- Abbott Laboratories
- Abiomed, Inc.
- Berlin Heart Gmbh
- Calon Cardio-Technology Ltd
- Cleveland Heart, Inc.
- Corwave
- Evaheart, Inc.
- Fineheart Sarl
- Fresenius Medical Care & Co. Kgaa
- Jarvik Heart
- Leviticus-Cardio Ltd.
- Medtronic Plc
- Mitiheart Corporation
- Procyrion
- Reliant Heart
- Tandemlife
- Windmill Cardiovascular Systems, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/b...entricular
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Cardiovascular Devices
